James Loerop was appointed as executive vice president of business development and strategic planning, a newly created position at Anika Therapeutics.
Three things to know:
1. Mr. Loerop will supervise Anika's global business development including management of new business opportunities, initiatives, mergers, acquisitions, partnerships and licensing agreements.
2. He has over 30 years of experience in business and corporate development in the biopharma sector.
3. Mr. Loerop served in leadership roles at Lupin Pharmaceuticals, Alexion Pharmaceuticals, GlaxoSmithKline and Steifel Laboratories.
"Jim's depth of knowledge and experience will be instrumental to the refinement and execution of our long-term growth strategy, which will include identifying partnership opportunities to expand our commercial portfolio and global footprint," said Joseph Darling, President and CEO of Anika.